MedPath

An efficacy evaluation of hair oil for hair fall reduction, growth and strengthening of hair in healthy Indian human volunteers

Not Applicable
Completed
Registration Number
CTRI/2013/10/004079
Lead Sponsor
Dabur India Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

•Subjects in general good health.

•Subjects in the age group 18-45 years (both the ages inclusive)

•Subjects willing to give a written informed consent and agree to come for a regular follow up visit.

•Subjects complaining of hair loss, hair fall and damage

•Subjects willing to abide by and comply with the study protocol.

•Subjects who have not participated in a similar investigation in the past four weeks.

•Subjects who have not used hair oil in past 2 weeks

•Subjects who have not undergone any hair therapy in minimum 3 months

•Healthy volunteers with no known allergy to any of the test ingredients

•Subjects who show no sensitivity to test product.

•Subjects who are not on dieting.

•Subjects who are willing to refrain from using dyes/henna/hair treatment throughout the study.

•Subjects willing not to tie hair tightly.

Exclusion Criteria

•Subjects who are undergoing hair growth or hair straightening or transplant treatment 3 months before screening into the study

•Subjects who have diseased Scalp conditions at the time of screening.

•Subjects who have alopecia areata

•Subjects who have treatments of chemotherapy within 6 months before starting study

•Subjects who have history of addiction or drug abuse or psychiatric disorder

•Subjects who use hairpiece during study terms

•Subjects on oral medications or suffering from chronic illness which will compromise the study.

•Subjects who are pregnant lactating or nursing

•Subjects participating in other similar cosmetic or therapeutic trial.

•Any underlying uncontrolled medical illness

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in hair growth,reduction of hair fall and strength of hair in comparison to baseline as determined by Dermatological assessmentTimepoint: 12 weeks
Secondary Outcome Measures
NameTimeMethod
â?¢Safety of Investigational product by dermatologist and subjects. <br/ ><br>â?¢Improvement in overall condition of hair as assessed by dermatological and subject <br/ ><br>Timepoint: 12 weeks
© Copyright 2025. All Rights Reserved by MedPath